Engelhardt Sean, Morley Ciara, Van Rooyen Janus, Thiart Fredalet, Masemola Katlego, Boda Muhammad, Luvhengo Thifhelimbilu
School of Clinical Medicine, University of the Witwatersrand, Johannesburg, Republic of South Africa.
Clinical Head Department of Surgery, CMJAH, University of the Witwatersrand, Johannesburg, Republic of South Africa.
Ann Med Surg (Lond). 2025 Mar 28;87(5):2645-2652. doi: 10.1097/MS9.0000000000003197. eCollection 2025 May.
Various comorbidities are known to exacerbate the risk of surgical mortality with COVID-19 infection. The effect of HIV infection on surgical mortality in the context of COVID-19 has also not been investigated. The aim of our study was to investigate the influence of HIV status on mortality in surgical patients admitted during the COVID-19 pandemic in Johannesburg, South Africa.
We reviewed records of patients who were admitted and underwent surgery during the COVID-19 pandemic and died. Data regarding perioperative COVID-19 infection, risk factors, comorbidities, mortality preventability, and contributing factors were extracted. Logistic regression was used to analyze comorbidities associated with COVID-19 infection among surgical mortalities.
A total of 404 records of mortalities were found and 25% (82/404) tested positive for COVID-19. 40% Of the mortalities were either potentially preventable or preventable. Comorbidities in patients who were COVID-19-positive surgical mortalities compared to their negative counterparts included smoking in 35% versus 4%, chronic obstructive pulmonary disease (COPD) in 20% versus 3%, and diabetes mellitus in 23% versus 13%, respectively. The odds of being COVID-19 positive in surgical mortalities with hypertension, smoking, and COPD were 1.96 times [OR = 1.96, 95% CI (1.06, 3.59)], 7.78 times [OR = 7.78, 95% CI (3.45, 18.35)], and 3.09 times [OR = 3.09, 95% CI (1.08, 8.95)], respectively. 55% of COVID-19-positive patients who died were HIV positive compared to 31% among the COVID-19-negative group. 26% of HIV-positive patients were on anti-retroviral treatment (ART). 22% of HIV-/COVID-19-coinfected surgical mortalities were not on antiretroviral treatment compared to 9% in the HIV-positive and COVID-19-negative groups. The odds of COVID-19 infection in surgical mortalities who were HIV positive and not on ART was 3.10 [95% CI (1.55, 6.11)].
The rate of COVID-19 infection was higher in HIV-positive patients who died, especially if they were not on ART. Smoking, COPD, and hypertension imparted the largest risk on COVID-19 infection in cases of surgical mortality. These comorbidities likely superimpose the pathological effects of COVID-19 infection, worsening surgical prognosis.
已知多种合并症会增加 COVID-19 感染患者手术死亡风险。HIV 感染对 COVID-19 患者手术死亡率的影响尚未得到研究。我们研究的目的是调查 HIV 状态对南非约翰内斯堡 COVID-19 大流行期间入院手术患者死亡率的影响。
我们回顾了 COVID-19 大流行期间入院并接受手术且死亡患者的记录。提取了围手术期 COVID-19 感染、危险因素、合并症、死亡可预防性及促成因素等数据。采用逻辑回归分析手术死亡患者中与 COVID-19 感染相关的合并症。
共找到 404 份死亡记录,其中 25%(82/404)的患者 COVID-19 检测呈阳性。40%的死亡病例为潜在可预防或可预防的。与 COVID-19 检测阴性的手术死亡患者相比,COVID-19 检测阳性患者的合并症包括吸烟,分别为 35%和 4%;慢性阻塞性肺疾病(COPD),分别为 20%和 3%;糖尿病,分别为 23%和 13%。患有高血压、吸烟和 COPD 的手术死亡患者中 COVID-19 检测呈阳性的几率分别为 1.96 倍[OR = 1.96,95%CI(1.06,3.59)]、7.78 倍[OR = 7.78,95%CI(3.45,18.35)]和 3.09 倍[OR = 3.09,95%CI(1.08,8.95)]。死亡的 COVID-19 检测阳性患者中有 55%为 HIV 阳性,而 COVID-19 检测阴性组中这一比例为 31%。26%的 HIV 阳性患者正在接受抗逆转录病毒治疗(ART)。HIV 与 COVID-19 合并感染的手术死亡患者中,22%未接受抗逆转录病毒治疗,而 HIV 阳性且 COVID-19 检测阴性组中这一比例为 9%。HIV 阳性且未接受 ART 的手术死亡患者中 COVID-19 感染的几率为 3.10[95%CI(1.55,6.11)]。
死亡的 HIV 阳性患者中 COVID-19 感染率较高,尤其是未接受 ART 的患者。吸烟、COPD 和高血压在手术死亡病例中对 COVID-19 感染的风险影响最大。这些合并症可能叠加 COVID-19 感染的病理效应,使手术预后恶化。